🔗 Share this article

Given that America continues making sweeping changes to its vaccination schedules, an unexpected name appears in a surprising turn: Dr. Tracy Beth Høeg, a Danish American sports medicine doctor and epidemiologist who initially gained attention by casting doubt on Covid vaccines in the pandemic and has focused upon possible deaths following Covid vaccination in her brief position at the Food and Drug Administration.

Proposed Overhauls to Childhood Immunization Program

Health officials had intended to unveil major revisions to the childhood immunization program in December, bringing the US with the Danish vaccine program, sources say – a major change that would place the US out of alignment with many the world with no evidence for public health gain. This reveal has been delayed until the coming year.

Instead of Vinay Prasad, Høeg is set to present at the meeting. She was just designated temporary leader of the FDA’s drug evaluation center, the fifth appointee to head the division this year.

Consolidating Power at the Agency

This interim role could signify a strengthened alliance between the pharmaceutical and vaccine divisions as Dr. Høeg and Dr. Prasad solidify control at the agency – and it suggests a greater focus upon dismantling long-standing vaccines at the FDA.

Dr. Høeg has frequently advocated for ending specific childhood immunization guidelines in the US so as to align more in line with the Danish model, a nation with universal health coverage and a population roughly the size of the state of Wisconsin.

So far statements, she has continued to focus on immunizations – typically the domain of Dr. Prasad, head of the FDA’s CBER – rather than medication approval.

Doubts Over Background

Høeg has no obvious background in medication creation, approval processes or leadership, which has been typical for former heads of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a key advisor to the FDA chief and CBER since March.

“She doesn’t seem to have the requisite experience” for running the CDER, stated a neurologist and psychiatrist. “She lacks experience running a scientific study. She has no expertise in running a sizeable institution. She is not an expert in drug approvals.”

Past heads of the center would “be deeply familiar with regulatory frameworks and the underlying principles of pharmaceutical innovation”, said a former acting FDA commissioner. “Clearly, she has not acquired the type of experience that previous people who headed the center have had.”

CDER has an vast workload at the agency, the former commissioner emphasized.

“Everybody just zeroes in on the new drug program, but the generic program authorizes a multitude of generic drugs. There’s a biosimilars program, OTC medication office and other areas, and every single one have to be looked after,” she noted. “The area you don’t keep your eye on, that is the part that I always told people is going to come back to haunt you.”

Additionally, a major administrative element to the role, which supervises more than 5,000 employees. “It is a huge leadership role, if you do it right,” the former official concluded.

Response and Contentious Programs

When asked about concerns about Dr. Høeg's credentials and whether this appointment signifies increased cooperation among regulatory chiefs on vaccines, a spokesperson stated that the “concerns rely on flawed presumptions”.

“Her experience is consistent with the duties of her role,” the official explained, pointing to the period Dr. Høeg spent counseling the agency head on “drug safety and regulatory science, including computerized risk analysis and shot safety tracking”.

As the temporary head, Høeg assumes responsibility for the agency head's controversial expedited review system, a controversial expedited drug-approval program that apparently worried her preceding directors. “By what process are these drugs being selected for this voucher program? Who makes the choices?” Dr. Howard questioned. “There’s a lot of secrecy occurring at the FDA right now.”

Broadly speaking, he stated, “the FDA seems to be moving towards laxer oversight of most medications, except for immunizations.”

Established Track Record on Vaccines

Concerning immunizations, Høeg has a clearer, if troubling, track record, critics said. She released a research paper using unconfirmed volunteer-provided data to estimate the frequency of heart inflammation following COVID-19 immunization. She consulted for the state of Florida top health official Dr. Joseph Ladapo, who allegedly have changed statistics to suggest Covid vaccinations are pose a greater threat than they are.

Part of her “policy goals” for the current federal leadership featured revising regulations for new vaccines and discontinuing “optional” vaccines, she stated following the vote on a online show. At the agency, Dr. Høeg has allegedly floated the idea of barring teenage boys from receiving Covid vaccinations.

“She’s an thorough dogmatist who commences with her conclusions and tailors the evidence to accommodate the science in a highly disingenuous, fraudulent manner,” Dr. Howard stated.

Consolidating Power and a “Revenge Tour”

Høeg became part of other skeptics, {like|